23 May 2013
Keywords: merck, co, submits, nda, vioxx, submitted, new
Article | 25 November 1998
Merck & Co has submitted a New Drug Application to the US Food and DrugAdministration for its anti-inflammatory, once-daily COX-2 inhibitor ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.